Inhibitor Therapeutics (INTI) Liabilities and Shareholders Equity (2012 - 2026)
Inhibitor Therapeutics (INTI) reported Liabilities and Shareholders Equity of $637,190 for Q2 2026, down 83.7% from $3.91 million a year earlier and down 55.5% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics posted Liabilities and Shareholders Equity of $2.51 million, down 55.9% from FY2024.
- Liabilities and Shareholders Equity has declined for three consecutive years, though with a five-year compound annual growth rate of 80.3% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $5.69 million in FY2024 (-36.4%), $8.95 million in FY2023 (-25.3%), $11.98 million in FY2022 and $58,784 in FY2021 (-55.4%).
- The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q3 2022.
- Year over year, Liabilities and Shareholders Equity has now declined in each of the last 11 quarters, with an average decline of 52.0% over the last eight quarters.
- Across the past five years, year-over-year decline in Liabilities and Shareholders Equity ran from 10.8% in Q3 2021 to 83.7% in Q2 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.43 million (Q1 2026), $2.51 million (Q4 2025) and $3.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 637,190.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 637,190.00 |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 3.14 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 5.69 Mn |
| Sep 30, 2024 | 6.45 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | 7.79 Mn |
| Dec 31, 2023 | 8.95 Mn |
| Sep 30, 2023 | 9.61 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 10.84 Mn |
| Dec 31, 2022 | 11.98 Mn |
| Sep 30, 2022 | 63,117.00 |
| Jun 30, 2022 | 38,517.00 |
| Mar 31, 2022 | 61,143.00 |
| Dec 31, 2021 | 58,784.00 |
| Sep 30, 2021 | 92,518.00 |
API Access
Inhibitor Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();